Can I sell or license my company's lab notebooks and research records to AI companies?
Yes. Buyers list lab notebooks and lab protocols as wanted, and the published ceiling for chemistry and materials research records is $250K–$500K. License a copy and never delete the original, since FDA rules require nonclinical study raw data to be kept for years.
What could your company's records earn? Get a range in 30 seconds. Free, no obligation.
Why do AI buyers want lab records?
Science models need to see experiments as they were run: the plan, the failed attempts, the measurements and the reasoning. Published papers show only the successes. Lab notebooks show everything, which is why buyer lists name lab notebooks, lab protocols and R&D records as wanted (buyer program pages and listings, read 20 and 21 Nov 2026).
What is the published price band?
One listing covers chemistry and materials-science R&D records, with a ceiling of $250K–$500K (buyer listing, read 20 Nov 2026; company size not stated). Semiconductor and materials companies with 10 to 2,000 staff show $500K–$750K, partly for design and test data. Quotes depend on years of notebooks, whether they are digital and how well they are labeled. Use the calculator.
Do I have to keep the originals?
Yes, where rules apply. FDA's rule on good laboratory practice for nonclinical studies requires documentation, raw data and specimens to be kept in an archive for the shortest of: at least 2 years after the FDA approves the related application; at least 5 years after the results are submitted to FDA; or, where no submission follows, at least 2 years after the study ends (21 CFR 58.195, eCFR). Licensing a copy does not touch those duties. Never hand over your only copy, and never delete the original to "deliver" it.
How are notebooks collected?
- Electronic lab notebooks: export entries and attachments as PDF, XML or JSON through the vendor's export tool.
- Instrument data: spectra, assay plates and logs exported from instrument software.
- Paper notebooks: scanned, ideally with text extraction. Handwriting needs extra work and buyers value it less.
- Shared drives: protocols and reports collected as documents; see documents and wikis.
A good export keeps dates, authors' roles and links between an experiment and its results.
Who owns the research?
Ownership depends on your employment and funding agreements. Work done for a sponsor, a grant, a university or a contract research customer may belong to that party, and a patent filing can be hurt by disclosure before it is filed. Ask your patent counsel which notebooks to hold back and when.
What gets removed or excluded?
- Anything tied to unfiled inventions or pending patents.
- Sponsor-owned or partner-owned studies.
- Human-subject data, which needs de-identification; see clinical records.
- Formulas and recipes that are your core trade secrets.
- Researcher names, replaced with placeholders.
Which organizations hold the most?
Biotech and pharma, specialty chemicals, materials and battery makers, food science, semiconductor firms and contract research organizations. A decade of digital notebooks with failed experiments recorded is the best case.
Questions
Will licensing destroy my patent rights?
It can if an unpublished invention is disclosed. A buyer under confidentiality terms may be fine, but ask patent counsel first.
Are paper notebooks worth scanning?
Sometimes. Ask for a pilot on a few notebooks before you scan everything.
Does the buyer keep my formulas?
Only for the term and uses in the license. See contract clauses.
Sources
- eCFR, 21 CFR 58.195, "Retention of records": https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-58/subpart-J/section-58.195
- Buyer program pages and listings, read 20 and 21 Nov 2026 (buyers not named by policy).